RDHL
Redhill Biopharma LtdNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$5.09M
P/E Ratio
0.00
EPS
$0.00
Beta
5.04
52W High
$3.31
52W Low
$0.71
50-Day MA
$0.91
200-Day MA
$1.21
Dividend Yield
—
Profit Margin
-150.00%
Forward P/E
1428.57
PEG Ratio
0.00
About Redhill Biopharma Ltd
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focused on gastrointestinal and infectious diseases. The company is headquartered in Tel Aviv, Israel.
Fundamentals
| Revenue (TTM) | 286,000 |
| Gross Profit (TTM) | 286,000 |
| EBITDA | $-7.79M |
| Operating Margin | -2765.00% |
| Return on Equity | -1709.00% |
| Return on Assets | -22.80% |
| Revenue/Share (TTM) | $0.09 |
| Book Value | $0.84 |
| Price-to-Book | 1.19 |
| Price-to-Sales (TTM) | 17.78 |
| EV/Revenue | 7.64 |
| EV/EBITDA | 0.30 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 58.60% |
| Shares Outstanding | $5.19M |
| Float | $39.91B |
| % Insiders | 0.00% |
| % Institutions | 9.99% |
Historical Volatility
HV 10-Day
63.86%
HV 20-Day
50.42%
HV 30-Day
73.60%
HV 60-Day
66.61%
HV Rank
40.5%
Volatility is currently contracting
More HEALTHCARE Stocks
Data last updated: 5/25/2026